News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Salzman Amber
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2020 |
4
| Salzman Amber (Director) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Disposed/sold 53,000 options to buy
@ $17.94, valued at
$950.8k
Disposed/sold 26,400 options to buy
@ $16.14, valued at
$426.1k
|
|
| 04/15/2020 |
4
| Salzman Amber (Director) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 26,400 options to buy
@ $16.14, valued at
$426.1k
|
|
| 02/13/2020 |
4
| Salzman Amber (Director) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 53,000 options to buy
@ $17.94, valued at
$950.8k
|
|
| 02/13/2020 |
3
| Salzman Amber (Director) has filed a Form 3 on AKCEA THERAPEUTICS, INC. |
| 02/20/2018 |
4
| Salzman Amber (President and CEO) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 478,000 options to buy
@ $6.4, valued at
$3.1M
|
|
| 02/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/13/2016 |
4
| Salzman Amber (President and COO) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 629,766 shares
@ $0
Granted 377,890 options to buy
@ $0
Granted 218,000 options to buy
@ $4.14, valued at
$902.5k
|
|
| 05/13/2016 |
3
| Salzman Amber (President and COO) has filed a Form 3 on Adverum Biotechnologies, Inc. |
|
|